# BWX Technologies, Inc.: Form 10-Q for the period ended Mar 31, 2018

- Company: [BWX Technologies, Inc.](/companies/bwxt.md) (CIK 1486957)
- Form: 10-Q
- Filed: 2018-05-04
- Accepted by EDGAR: May 4, 2018, 16:47 ET
- Period: 2018-03-31
- Accession: 0001486957-18-000021
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1486957/000148695718000021/bwxt_33118x10qdocument.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1486957/000148695718000021/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-01-01 to 2018-03-31 | $459.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $327.4m | us-gaap:CostOfRevenue |
| Research and development | 3 months, 2018-01-01 to 2018-03-31 | $3.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-01-01 to 2018-03-31 | $53.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | $79.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-01-01 to 2018-03-31 | $3.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $18.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | $66.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-01 to 2018-03-31 | $0.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 100,512,287 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-01-01 to 2018-03-31 | −$18.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $17.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2018-01-01 to 2018-03-31 | $15.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2018-03-31 | $143.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $702.9m | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $1.54bn | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $327.1m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2018-03-31 | $471.4m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2018-03-31 | $345.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 33,434 characters.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included under Item 1 of this quarterly report on Form 10-Q ("Report") and the audited consolidated financial statements and the related notes and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our annual report on Form 10-K for the year ended December 31, 2017 (our "2017 10-K").

In this Report, unless the context otherwise indicates, "we," "us" and "our" mean BWX Technologies, Inc. ("BWXT") and its consolidated subsidiaries.

From time to time, our management or persons acting on our behalf make forward-looking statements to inform existing and potential security holders about our company. In addition, various statements in this Report, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934. Statements and assumptions regarding expectations and projections of specific projects, our future backlog, revenues, income, capital spending, strategic investments, acquisitions or divestitures, research and development initiatives, return on capital activities or margin improvement initiatives are examples of forward-looking statements. Forward-looking statements are generally accompanied by words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "plan," "seek," "goal," "could," "intend," "may," "should" or other words that convey the uncertainty of future events or outcomes. In addition, sometimes we will specifically describe a statement as being a forward-looking statement and refer to this cautionary statement.

We have based our forward-looking statements on our current expectations, estimates and projections about our industries and our company. We caution that these statements are not guarantees of future performance and you should not rely unduly on them, as they involve risks, uncertainties and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. While our management considers these assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements.

We believe the items we have outlined above are important factors that could cause estimates in our financial statements to differ materially from actual results and those expressed in a forward-looking statement made in this Report or elsewhere by us or on our behalf. Differences between actual results and any future performance suggested in our forward-looking statements could result from a variety of factors. We have discussed many of these factors in more detail elsewhere in this Report and in Item 1A "Risk Factors" in our 2017 10-K. These factors are not necessarily all the factors that could affect us. Unpredictable or unanticipated factors we have not discussed in this Report or in our 2017 10-K could also have material adverse effects on actual results of matters that are the subject of our forward-looking statements. We do not intend to update our description of important factors each time a potential important factor arises, except as required by applicable securities laws and regulations. We advise our security holders that they should (1) be aware that factors not referred to above could affect the accuracy of our forward-looking statements and (2) use caution and common sense when considering our forward-looking statements.

GENERAL

We operate in three reportable segments: Nuclear Operations Group, Nuclear Services Group and Nuclear Power Group. In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We are currently exploring growth strategies across our segments to expand and complement our existing businesses. We would expect to fund these opportunities with cash on hand or by raising additional capital through debt, equity or some combination thereof.

### Nuclear Operations Group

The revenues of our Nuclear Operations Group segment are largely a function of defense spending by the U.S. Government. Through this segment, we engineer, design and manufacture precision naval nuclear components, reactors and nuclear fuel for the DOE/NNSA's Naval Nuclear Propulsion Program. In addition, we perform development and fabrication activities for missile launch tubes for U.S. Navy submarines. As a supplier of major nuclear components for certain U.S. Government programs, this segment is a significant participant in the defense industry.

### Nuclear Services Group

Our Nuclear Services Group segment provides various services to the U.S. Government and the commercial nuclear industry primarily in the U.S. The revenues and equity in income of investees under our U.S. Government contracts are largely a function of spending of the U.S. Government and the performance scores we and our consortium partners earn in managing and operating high-consequence operations at U.S. nuclear weapons sites, national laboratories and manufacturing complexes. With its specialized capabilities of full life-cycle management of special materials, facilities and technologies, we believe our Nuclear Services Group segment is well-positioned to continue to participate in the continuing cleanup, operation and management of critical government-owned nuclear sites, laboratories and manufacturing complexes maintained by the DOE, NASA and other federal agencies.

This segment is also engaged in inspection and maintenance services for the commercial nuclear industry primarily in the U.S. These services include the inspection of steam generators and heat exchangers, high pressure water lancing, non-destructive examination and the development of customized tooling solutions. This segment also develops technology for a variety of applications, including advanced nuclear power sources, and offers complete advanced fuel and reactor engineering, licensing and manufacturing services for new advanced nuclear reactors.

### Nuclear Power Group

Through this segment, we design and manufacture commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. This segment is a leading supplier of nuclear fuel, fuel handling systems, tooling delivery systems and related services for CANDU nuclear power plants. This segment also provides a variety of engineering and in-plant services and is a significant supplier to nuclear power utilities undergoing major refurbishment and plant life extension projects.

Our Nuclear Power Group segment's overall activity primarily depends on the demand and competitiveness of nuclear energy. A significant portion of our Nuclear Power Group segment's operations depend on the timing of maintenance outages, principally in the Canadian market, and the cyclical nature of capital expenditures and major refurbishments for nuclear utility customers, which could cause variability in our financial results.

### Acquisition of Sotera Health LLC's Nordion Medical Isotope Business

On April 17, 2018, we signed a definitive agreement to acquire Sotera Health LLC's Nordion medical isotope business. Nordion's medical radioisotopes business is a leading global manufacturer and supplier of critical medical isotopes and radiopharmaceuticals for research, diagnostic and therapeutic uses. Its customers include radiopharmaceutical companies, hospitals and radiopharmacies. Its primary operations are located in Kanata, Ontario and Vancouver, British Columbia. This acquisition will allow us to accelerate our entry into the medical radioisotope market by adding licensed infrastructure, approximately 150 highly trained and experienced personnel and two production centers. Subject to required Canadian and U.S. regulatory reviews and approvals, this transaction is expected to close by the end of 2018.

### Critical Accounting Policies and Estimates

For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited condensed consolidated financial statements, see Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2017 10-K. There have been no material changes to our policies during the three months ended March 31, 2018 with the exception of changes to FASB Topics *Revenue from Contracts with Customers* and *Compensation – Retirement Benefits* as described in the notes to our condensed consolidated financial statements in Item 1 of this Report.

### Accounting for Contracts

On certain of our performance obligations, we recognize revenue over time. In accordance with FASB Topic *Revenue from Contracts with Customers*, we are required to estimate the total amount of costs on these performance obligations. As of March 31, 2018, we have provided for the estimated costs to complete all of our ongoing contracts. However, it is possible that current estimates could change due to unforeseen events, which could result in adjustments to overall contract costs. A principal risk on fixed-priced contracts is that revenue from the customer is insufficient to cover increases in our costs. It is possible that current estimates could materially change for various reasons, including, but not limited to, fluctuations in forecasted labor productivity or steel and other raw material prices. In some instances, we guarantee completion dates related to our projects or provide performance guarantees. Increases in costs on our fixed-price contracts could have a material adverse impact on our consolidated results of operations, financial condition and cash flows. Alternatively, reductions in overall contract costs at completion could materially improve our consolidated results of operations, financial condition and cash flows. In the three months ended March 31, 2018 and 2017, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $5.3 million and $4.9 million, respectively.

RESULTS OF OPERATIONS – THREE MONTHS ENDED MARCH 31, 2018 VS. THREE MONTHS ENDED MARCH 31, 2017

Selected financial highlights are presented in the table below:

*(In thousands)*

| REVENUES: | Three Months Ended March 31, 2018 | 2017 | $ Change |
| --- | ---: | ---: | ---: |
| Nuclear Operations Group | $316,631 | $325,081 | $(8,450) |
| Nuclear Services Group | 30,033 | 27,854 | 2,179 |
| Nuclear Power Group | 112,816 | 77,674 | 35,142 |
| Adjustments and Eliminations | (2,017) | (2,380) | 363 |
|  | $457,463 | $428,229 | $29,234 |
| OPERATING INCOME: |  |  |  |
| Nuclear Operations Group | $67,657 | $67,749 | $(92) |
| Nuclear Services Group | 1,177 | 402 | 775 |
| Nuclear Power Group | 21,764 | 12,956 | 8,808 |
| Other | (4,043) | (1,612) | (2,431) |
|  | $86,555 | $79,495 | $7,060 |
| Unallocated Corporate | (6,667) | (3,223) | (3,444) |
| Total Operating Income | $79,888 | $76,272 | $3,616 |

#### Consolidated Results of Operations

#### Three months ended March 31, 2018 vs. 2017

Consolidated revenues increased 6.8%, or $29.2 million, to $457.5 million in the three months ended March 31, 2018 compared to $428.2 million for the corresponding period in 2017, due to increases in revenues from our Nuclear Services Group and Nuclear Power Group segments totaling $2.2 million and $35.1 million, respectively. These increases were partially offset by a decrease in revenues in our Nuclear Operations Group segment of $8.5 million.

Consolidated operating income increased $3.6 million to $79.9 million in the three months ended March 31, 2018 compared to $76.3 million for the corresponding period of 2017. We experienced operating income improvements in our Nuclear Services Group and Nuclear Power Group segments of $0.8 million and $8.8 million, respectively. These increases were partially offset by lower operating income in our Nuclear Operations Group and Other segments of $0.1 and $2.4 million, respectively, as well as an increase in unallocated corporate expenses of $3.4 million.

#### Nuclear Operations Group

*(In thousands)*

|  | Three Months Ended March 31, 2018 | 2017 | $ Change |
| --- | ---: | ---: | ---: |
| Revenues | $316,631 | $325,081 | $(8,450) |
| Operating Income | 67,657 | 67,749 | (92) |
| % of Revenues | 21.4% | 20.8% |  |

25

#### Three months ended March 31, 2018 vs. 2017

Revenues decreased 2.6%, or $8.5 million, to $316.6 million in the three months ended March 31, 2018 compared to $325.1 million for the corresponding period of 2017. The decrease was primarily attributable to lower activity in the manufacturing of nuclear components for U.S. Government programs.

Operating income decreased $0.1 million to $67.7 million in the three months ended March 31, 2018 compared to $67.7 million for the corresponding period of 2017. The decrease was primarily driven by the changes in revenue noted above, which was offset by net favorable changes in estimates related to certain long-term contracts within our naval nuclear fuel and downblending operations.

#### Nuclear Services Group

*(In thousands)*

|  | Three Months Ended March 31, 2018 | 2017 | $ Change |
| --- | ---: | ---: | ---: |
| Revenues | $30,033 | $27,854 | $2,179 |
| Operating Income | 1,177 | 402 | 775 |
| % of Revenues | 3.9% | 1.4% |  |

#### Three months ended March 31, 2018 vs. 2017

Revenues increased 7.8%, or $2.2 million, to $30.0 million in the three months ended March 31, 2018 compared to $27.9 million for the corresponding period of 2017. The increase was primarily attributable to increased activity at our Naval Reactor decommissioning and decontamination project of $2.9 million and an increase in design and engineering revenues in support of NASA's nuclear space programs. These increases were partially offset by a decline in revenue associated with cost reimbursable activities at some of the sites we manage and operate.

Operating income increased $0.8 million to $1.2 million in the three months ended March 31, 2018 compared to $0.4 million for the corresponding period of 2017. The increase was primarily attributable to lower selling, general and administrative expenses related to a decrease in business development activities caused by the timing of proposal activities.

#### Nuclear Power Group

*(In thousands)*

|  | Three Months Ended March 31, 2018 | 2017 | $ Change |
| --- | ---: | ---: | ---: |
| Revenues | $112,816 | $77,674 | $35,142 |
| Operating Income | 21,764 | 12,956 | 8,808 |
| % of Revenues | 19.3% | 16.7% |  |

#### Three months ended March 31, 2018 vs. 2017

Revenues increased 45.2%, or $35.1 million, to $112.8 million in the three months ended March 31, 2018 compared to $77.7 million for the corresponding period of 2017. The increase was primarily attributable to an increase in revenues in our nuclear components business of $17.8 million as a result of an increase in design and manufacturing work associated with the China steam generator project and higher levels of in-plant inspection, maintenance and modification services totaling $11.1 million. In addition, we also experienced an increase in volume related to the fabrication of nuclear fuel and higher levels of activity associated with our nuclear fuel handling capabilities.

Operating income increased $8.8 million to $21.8 million in the three months ended March 31, 2018 compared to $13.0 million for the corresponding period of 2017, primarily attributable to increases in revenue noted above. In addition, operating income improved as a result of lower selling, general and administrative expenses of $0.9 million, which was largely related to the integration of BWXT Nuclear Energy Canada Inc. (acquired December 16, 2016) into our existing business.

#### Other

*(In thousands)*

|  | Three Months Ended March 31, 2018 | 2017 | $ Change |
| --- | ---: | ---: | ---: |
| Operating Income | (4,043) | (1,612) | (2,431) |

Operating income decreased $2.4 million to a loss of $4.0 million in the three months ended March 31, 2018 compared to a loss of $1.6 million for the corresponding period of 2017, primarily due to an increase in research and development activities related to our medical and industrial radioisotope capabilities.

#### Unallocated Corporate

Unallocated corporate expenses increased $3.4 million to $6.7 million for the three months ended March 31, 2018 compared to $3.2 million for the corresponding period of 2017. This increase was primarily due to third-party costs associated with due diligence activities and higher levels of stock-based compensation, which were partially offset by lower healthcare claims.

#### Provision for Income Taxes

*(In thousands)*

|  | Three Months Ended March 31, 2018 | 2017 | $ Change |
| --- | ---: | ---: | ---: |
| Income before Provision for Income Taxes | $85,016 | $80,378 | $4,638 |
| Provision for Income Taxes | $18,603 | $24,592 | $(5,989) |
| Effective Tax Rate | 21.9% | 30.6% |  |

We primarily operate in the U.S. and Canada. On December 22, 2017, the Tax Cuts and Jobs Act (the "Act") was enacted, making significant changes to existing U.S. tax laws that impact BWXT, including, but not limited to, a reduction to the U.S. corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017, the taxation of global intangible low-taxed income ("GILTI") and additional deduction limitations related to executive compensation. We recognized the income tax effects of the Act within our condensed consolidated financial statements in accordance with Financial Accounting Standards Board Topic *Income Taxes*. Our Canadian operations continue to be subject to tax at a local statutory rate of approximately 25%.

Our effective tax rate for the three months ended March 31, 2018 was 21.9% as compared to 30.6% for the three months ended March 31, 2017. The effective tax rate for the three months ended March 31, 2018 was slightly higher than the U.S. corporate income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings. Our effective tax rate for the three months ended March 31, 2018 and March 31, 2017 was favorably impacted by benefits recognized for excess tax benefits related to employee share-based payments of $2.2 million and $2.3 million, respectively.

#### Backlog

Backlog represents the dollar amount of revenue we expect to recognize in the future from contracts awarded and in progress. Not all of our expected revenue from a contract award is recorded in backlog for a variety of reasons, including that some projects are awarded and completed within the same fiscal quarter.

Our backlog is equal to our remaining performance obligations under contracts that meet the criteria in FASB Topic *Revenue from Contracts with Customers*, as discussed in Note 2 to our condensed consolidated financial statements included in this Report. It is possible that our methodology for determining backlog may not be comparable to methods used by other companies.

We are subject to the budgetary and appropriations cycle of the U.S. Government as it relates to our Nuclear Operations Group and Nuclear Services Group segments. Backlog may not be indicative of future operating results, and projects in our backlog may be cancelled, modified or otherwise altered by customers.

|  | March 31, 2018 (In approximate millions) | December 31, 2017 |
| --- | ---: | ---: |
| Nuclear Operations Group | $3,002 | $3,305 |
| Nuclear Services Group | 28 | 29 |
| Nuclear Power Group | 550 | 637 |
| Total Backlog | $3,580 | $3,971 |

We do not include the value of our unconsolidated joint venture contracts in backlog. These unconsolidated joint ventures are included in our Nuclear Services Group segment.

Of the March 31, 2018 backlog, we expect to recognize revenues as follows:

|  | 2018 (In approximate millions) | 2019 | Thereafter | Total |
| --- | ---: | ---: | ---: | ---: |
| Nuclear Operations Group | $944 | $802 | $1,256 | $3,002 |
| Nuclear Services Group | 21 | 3 | 4 | 28 |
| Nuclear Power Group | 168 | 111 | 271 | 550 |
| Total Backlog | $1,133 | $916 | $1,531 | $3,580 |

At March 31, 2018, Nuclear Operations Group backlog with the U.S. Government was $2,998.7 million, $283.5 million of which had not yet been funded.

At March 31, 2018, Nuclear Services Group backlog with the U.S. Government was $7.2 million, all of which was funded.

At March 31, 2018, Nuclear Power Group had no backlog with the U.S. Government.

Major new awards from the U.S. Government are typically received following congressional approval of the budget for the Government's next fiscal year, which starts October 1, and may not be awarded to us before the end of the calendar year. Due to the fact that most contracts awarded by the U.S. Government are subject to these annual funding approvals, the total values of the underlying programs are significantly larger. In April 2016, we were awarded a component and fuel contract, along with a three-year downblending contract by the U.S. Government with a combined value in excess of $3.0 billion, inclusive of unexercised options.

As of March 31, 2018, the U.S. Government had awarded us approximately $2.8 billion of the April 2016 award. The value of unexercised options excluded from backlog as of March 31, 2018 was approximately $0.2 billion, the majority of which is expected to be exercised in 2019, subject to annual congressional appropriations.

#### Liquidity and Capital Resources

#### Credit Facility

On September 2, 2016, we entered into an amendment (the "Amendment") to our Credit Agreement dated May 11, 2015 with Bank of America, N.A., as administrative agent, and certain lenders and letter of credit issuers party thereto (collectively, the "Amended Credit Agreement"). Prior to the Amendment, our Credit Agreement provided for a five-year, senior secured revolving credit facility in an aggregate amount of up to $400 million, the full amount of which was available for the issuance of letters of credit, and a senior secured term loan facility of $300 million, which was drawn on June 30, 2015. The Amendment added a new U.S. dollar term loan facility in an aggregate principal amount of up to $112.5 million, which was drawn on September 16, 2016, and a new Canadian dollar term loan facility in an aggregate principal amount of up to the equivalent of $137.5 million U.S. dollars, which was drawn on December 12, 2016 (collectively, the "Incremental Term Loans"). All obligations under the Amended Credit Agreement are scheduled to mature on June 30, 2020. The proceeds of loans under the Amended Credit Agreement are available for working capital needs and other general corporate purposes.

The Amended Credit Agreement includes provisions for additional financial institutions to become lenders, or for any existing lender to increase its commitment thereunder, subject to an aggregate maximum of $250 million for all additional term loans, revolving credit borrowings and letter of credit commitments.

The Amended Credit Agreement is (1) guaranteed by substantially all of our wholly owned domestic subsidiaries, excluding our captive insurance subsidiary, and (2) secured by first-priority liens on certain assets owned by us and the guarantors (other than our subsidiaries comprising our Nuclear Operations Group and a portion of our Nuclear Services Group segments).

The Amended Credit Agreement requires interest payments on revolving loans on a periodic basis until maturity. We began making quarterly amortization payments on the $300 million term loan in an amount equal to 1.25% of the aggregate principal amount in the first quarter of 2016. We began making quarterly amortization payments on the U.S. dollar term loan facility in an amount equal to 1.25% of the aggregate principal amount in the fourth quarter of 2016. We began making quarterly amortization payments on the Canadian dollar term loan facility in an amount equal to 1.25% of the aggregate principal amount in the first quarter of 2017. We may prepay all loans under the Amended Credit Agreement at any time without premium or penalty (other than customary Eurocurrency rate breakage costs), subject to notice requirements.

The Amended Credit Agreement includes financial covenants that are tested on a quarterly basis, based on the rolling four-quarter period that ends on the last day of each fiscal quarter. The maximum permitted leverage ratio is 3.00 to 1.00, which may be increased to 3.25 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated interest coverage ratio is 4.00 to 1.00. In addition, the Amended Credit Agreement contains various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales. At March 31, 2018, we were in compliance with all covenants set forth in the Amended Credit Agreement.

Outstanding loans under the Amended Credit Agreement bear interest at our option at either the Eurocurrency rate plus a margin ranging from 1.25% to 1.75% per year or the base rate (the highest of the Federal Funds rate plus 0.50%, the one-month Eurocurrency rate plus 1.0%, or the administrative agent's prime rate) plus a margin ranging from 0.25% to 0.75% per year. We are charged a commitment fee on the unused portion of the revolving credit facility, and that fee varies between 0.15% and 0.25% per year. Additionally, we are charged a letter of credit fee of between 1.25% and 1.75% per year with respect to the amount of each financial letter of credit issued under the Amended Credit Agreement, and a letter of credit fee of between 0.75% and 1.05% per year is charged with respect to the amount of each performance letter of credit issued under the Amended Credit Agreement. The applicable margin for loans, the commitment fee and the letter of credit fees set forth above will vary quarterly based on our leverage ratio. Based on the leverage ratio applicable at March 31, 2018, the margin for Eurocurrency rate and base rate loans was 1.375% and 0.375%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.375% and 0.825%, respectively, and the commitment fee for the unused portion of the revolving credit facility was 0.175%.

Upon the closing of the Credit Agreement and the subsequent Amendment, we paid certain upfront fees to the lenders thereunder, and paid arrangement and other fees to the arrangers and agents of the Amended Credit Agreement.

At March 31, 2018, borrowings outstanding totaled $502.8 million and $0.0 million under our term loans and revolving line of credit, respectively, and letters of credit issued under the Amended Credit Agreement totaled $73.8 million. As a result, we had $326.2 million available for borrowings or to meet letter of credit requirements as of March 31, 2018, excluding the additional $250 million available to us for term loan, revolving credit borrowings and letter of credit commitments. As of March 31, 2018, the weighted-average interest rate on outstanding borrowings under our Amended Credit Agreement was 3.18%.

The Amended Credit Agreement generally includes customary events of default for a secured credit facility, some of which allow for an opportunity to cure. If an event of default relating to bankruptcy or other insolvency events occurs under the Amended Credit Agreement, all obligations under the Amended Credit Agreement will immediately become due and payable. If any other event of default exists under the Amended Credit Agreement, the lenders will be permitted to accelerate the maturity of the obligations outstanding under the Amended Credit Agreement. If any event of default occurs under the Amended Credit Agreement, the lenders will be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.

If any default occurs under the Amended Credit Agreement, or if we are unable to make any of the representations and warranties in the Amended Credit Agreement, we will be unable to borrow funds or have letters of credit issued under the Amended Credit Agreement.

#### Other Arrangements

We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion. Although there can be no assurance that we will maintain our surety bonding capacity, we believe our current capacity is adequate to support our existing requirements for the next twelve months. In addition, these bonds generally indemnify the beneficiaries should we fail to perform our obligations under the applicable agreements. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of March 31, 2018, bonds issued and outstanding under these arrangements totaled approximately $60.8 million.

#### Long-term Benefit Obligations

Our unfunded pension and postretirement benefit obligations totaled $284.1 million at March 31, 2018. These long-term liabilities are expected to require use of our resources to satisfy future funding obligations. We expect to make contributions of approximately $25.6 million for the remainder of 2018 related to our pension plans and postretirement plans.

#### Other

Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of March 31, 2018 and December 31, 2017 were as follows:

*(In thousands)*

|  | March 31, 2018 | December 31, 2017 |
| --- | ---: | ---: |
| Domestic | $154,624 | $211,935 |
| Foreign | 6,657 | 13,443 |
| Total | $161,281 | $225,378 |

Our working capital increased by approximately $30.8 million to $375.8 million at March 31, 2018 from $345.0 million at December 31, 2017, primarily attributable to changes in net contracts in progress and advance billings due to the timing of project cash flows.

Our net cash used in operations decreased by $36.1 million to $18.6 million in the three months ended March 31, 2018, compared to $54.7 million in the three months ended March 31, 2017. The decrease in cash used in operations was largely attributable to changes in accounts receivable, accounts payable and accrued expenses, which were partially offset by the changes to net contracts in progress and advance billings noted above.

Our net cash used in investing activities increased by $0.8 million to $15.7 million in the three months ended March 31, 2018 compared to $14.9 million in the three months ended March 31, 2017. The increase was primarily attributable to an increase in purchases of property, plant and equipment, which were partially offset by a decrease in the purchases of securities and a decrease caused by the return of capital associated with one of our equity method investments related to a joint venture that was transitioned in 2017.

Our net cash used in financing activities increased by $64.0 million to $25.3 million in the three months ended March 31, 2018, compared to cash provided by financing activities of $38.7 million in the three months ended March 31, 2017. The increase was primarily attributable to a decrease in net borrowings and repayments under the Amended Credit Agreement of $50.1 million when compared to the same period of the prior year.

At March 31, 2018, we had restricted cash and cash equivalents totaling $8.0 million, $2.6 million of which was held for future decommissioning of facilities (which is included in other assets on our condensed consolidated balance sheets) and $5.4 million of which was held to meet reinsurance reserve requirements of our captive insurer.

At March 31, 2018, we had short-term and long-term investments with a fair value of $9.9 million. Our investment portfolio consists primarily of U.S. Government and agency securities, corporate bonds and equities, mutual funds and asset-backed securities. Our investments are carried at fair value and are either classified as trading, with unrealized gains and losses reported in earnings, or as available-for-sale, with unrealized gains and losses, net of tax, being reported as a component of other comprehensive income.

Based on our liquidity position, we believe we have sufficient cash and letter of credit and borrowing capacity to fund our operating requirements for at least the next 12 months.

## Market risk

As filed, 127 characters.

Our exposures to market risks have not changed materially from those disclosed in Item 7A included in Part II of our 2017 10-K.

## Controls and procedures

As filed, 1,996 characters.

As of the end of the period covered by this quarterly report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the SEC under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). This evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Our disclosure controls and procedures were developed through a process in which our management applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding the control objectives. You should note that the design of any system of disclosure controls and procedures is based in part upon various assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. Based on the evaluation referred to above, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures are effective as of March 31, 2018 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding disclosure. There has been no change in our internal control over financial reporting during the quarter ended March 31, 2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

### PART II

### OTHER INFORMATION

## Risk factors

As filed, 322 characters.

In addition to the other information in this report, the other factors presented in Item 1A Risk Factors in our 2017 10-K are some of the factors that could materially affect our business, financial condition or future results. There have been no material changes to our risk factors from those disclosed in our 2017 10-K.

Filed May 4, 2018.
Source: SEC EDGAR, the filing index for accession 0001486957-18-000021. Last ingested by Listed: Nov 14, 2026, 19:14 ET. No prices; not investment advice.
